Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyur Patel

Showing results (321-330 of 357) with videos related to

Pageof 36
Sort By:
American Journal of Hematology|November 15, 2017
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasmsRita Assi, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
Blood Advances|November 2, 2022
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AMLGhayas C Issa, Aram Bidikian, Sangeetha Venugopal, et al.
Digestive Diseases and Sciences|May 1, 2012
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infectionPaul J Clark, Alexander J Thompson, Qianqian Zhu, et al.
Journal of the American Heart Association|February 23, 2018
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term OutcomesAyman Samman Tahhan, Pratik Sandesara, Salim S Hayek, et al.
Canadian Liver Journal|August 22, 2022
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)Giada Sebastiani, Keyur Patel, Vlad Ratziu, et al.
Journal of Wound Care|April 20, 2023
Best practice for wound repair and regeneration use of cellular, acellular and matrix-like products (CAMPs)Stephanie Wu, Marissa Carter, Windy Cole, et al.
The American Journal of Gastroenterology|January 4, 2023
Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis BNorah A Terrault, Anna S Lok, Abdus S Wahed, et al.
Oncotarget|March 9, 2018
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsGuillermo Montalban-Bravo, Koichi Takahashi, Keyur Patel, et al.
American Journal of Hematology|April 3, 2021
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS)Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Faezeh Darbaniyan, et al.
Clinical Spine Surgery|May 8, 2026
Comparison Between Short-Term and 1-Year Patient-Reported Outcome Measures After Anterior Cervical Discectomy and FusionJonathan Dalton, Robert J Oris, Omar Tarawneh, et al.
Pageof 36

Showing results (321-330 of 357) with videos related to

Sort By:
Pageof 36
American Journal of Hematology|November 15, 2017
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasmsRita Assi, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
Blood Advances|November 2, 2022
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AMLGhayas C Issa, Aram Bidikian, Sangeetha Venugopal, et al.
Digestive Diseases and Sciences|May 1, 2012
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infectionPaul J Clark, Alexander J Thompson, Qianqian Zhu, et al.
Journal of the American Heart Association|February 23, 2018
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term OutcomesAyman Samman Tahhan, Pratik Sandesara, Salim S Hayek, et al.
Canadian Liver Journal|August 22, 2022
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)Giada Sebastiani, Keyur Patel, Vlad Ratziu, et al.
Journal of Wound Care|April 20, 2023
Best practice for wound repair and regeneration use of cellular, acellular and matrix-like products (CAMPs)Stephanie Wu, Marissa Carter, Windy Cole, et al.
The American Journal of Gastroenterology|January 4, 2023
Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis BNorah A Terrault, Anna S Lok, Abdus S Wahed, et al.
Oncotarget|March 9, 2018
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsGuillermo Montalban-Bravo, Koichi Takahashi, Keyur Patel, et al.
American Journal of Hematology|April 3, 2021
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS)Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Faezeh Darbaniyan, et al.
Clinical Spine Surgery|May 8, 2026
Comparison Between Short-Term and 1-Year Patient-Reported Outcome Measures After Anterior Cervical Discectomy and FusionJonathan Dalton, Robert J Oris, Omar Tarawneh, et al.
Pageof 36